Tim Showalter

Radiation oncologist; Artera clinical development team

[Trevor J. Royce MD MPH FASCO @tjroycemd]

In this episode we chat w ⁦@othman CEO/cofounder⁩ ⁦@Color⁩ - give us a listen for a story of impact and inspiration for how health technology can improve care delivery https://t.co/e3OyAhwHto

[ArteraAI @arteraAI]

We’re proud to have @Benioff on Artera’s board, helping shape how AI transforms precision medicine.

Check out his latest interview on the future of AI in business via @ChiefExecGrp: https://t.co/bMeuMuj9ru

#AIinHealthcare #MarcBenioff #Leadership

[Toni Choueiri, MD @DrChoueiri]

Congratulations to our friends and colleagues @arteraAI —their multimodal #ArtificialInteligence platform is revolutionary and applicable clinically. Bravo @arteraAI team! @TIME

https://t.co/YtQ1LAuKYQ

[Tim Showalter @TimShowalter1]

@BenMazer @DrChoueiri @arteraAI @TIME @AmerCancerCEO @DrRanaMcKay @DrPaulNguyen @JoshLangMD @AndreEsteva @felixfengmd @mishabeltran @AminaZoubeidi Good eye! You may think of us as a prostate company, but you’ll soon see that we have a much broader vision and upcoming impact. Stay tuned for publications in 2025

[Tim Showalter @TimShowalter1]

@CShahMD @AHNtoday @ManyamRusiaMD @DavidBartlettMD @Sushilberiwal @ColinChampMD Congrats!

[Fabio Schutz @FabioSchutz78]

Dr. @TimShowalter1 from @arteraAI presented the data from prostate cancer and discussed possibilities of integrating tissue AI analysis in RCC. Very promising to have AI integration in RCC. #KCRS23 @OncoAlert

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

Can we take lessons learned from #prostatecancer into #kidneycancer?
@TimShowalter1 says yes!

@kidneycan @kidneycancer @kcCURE #KCRS23

[Tim Showalter @TimShowalter1]

Thank you for the invitation to share the potential impact we can make together for patients with #RCC #KCRS23 @arteraAI

[Toni Choueiri, MD @DrChoueiri]

Elegant talk on how #AI can guide development of biomarkers in #RCC by @TimShowalter1
#KCRS23 @OncoAlert @kidneycan

[Tim Showalter @TimShowalter1]

@DanTrifMD @MayoCancerCare @MayoClinic @jasonpsheehan @NicholasZaorsky @EricLehrer @HenryRuizMD @joshuapalmermd @DoctorQMd @albertattia7 Superstar from the start! Congrats @DanTrifMD

[Tim Showalter @TimShowalter1]

@APDicker

[Tim Showalter @TimShowalter1]

So excited to take on this exciting role with a tremendous team of new friends and some old colleagues! @NGThaker_XRT @dougfloramd @scottpenberthy

[ArteraAI @arteraAI]

ArteraAI is proud to announce that our own Tim Showalter MD, MPh, is part of the groundbreaking new academic journal - the only peer-reviewed research journal dedicated to the advancement of #AI applications in clinical & precision #oncology: https://t.co/wUhn5C9LlA

[Tim Showalter @TimShowalter1]

Amazing work with direct clinical impact! Congrats to @DrSpratticus @NRGonc and the team at @arteraAI

[NEJM Evidence @NEJMEvidence]

This report used data derived and validated from completed randomized phase III trials to demonstrate that an AI-based predictive model could identify pts with predominately intermediate-risk #ProstateCancer who are likely to benefit from short-term androgen deprivation therapy.

[ArteraAI @arteraAI]

Are you passionate about #artificialintelligence and innovation in medical care? Join our team!

Are you looking to make a difference with your career? #ArteraAI is seeking a #ClinicalResearch Associate.

➡️ Get full job details and apply here today: https://t.co/HkioH1vA8x

[Tim Showalter @TimShowalter1]

So much fun getting to be a shark for this! Exciting to see the potential impact of AI in brachytherapy. Congratulations to all three of the presenters for compelling proposals and pitches.

[Sushil @Sushilberiwal]

Shark tank at ABS#2023 presentation on Chat GPT for brachy education ⁦@TimShowalter1⁩ ⁦@PranshuMohindra⁩

[Sushil @Sushilberiwal]

Shark tank at ABS#2023 presentation on Chat GPT for brachy education ⁦@TimShowalter1⁩ ⁦@PranshuMohindra⁩

[Tim Showalter @TimShowalter1]

@KamravaMD @Sushilberiwal @AmericanBrachy Agree!

[Tim Showalter @TimShowalter1]

Congrats to Kara and the UVA team on completing the trial! Very excited to see the great results

[Bethany Anderson @RadOncMom]

@romano_kara found BrachyGel packing is preferred by brachytherapists & patients with no difference in dose to the cervix or OAR! #ABSBrachy23

[Tim Showalter @TimShowalter1]

@mpdrc @WakeCancer @wakeforestmed @AtriumHealthWFB @LevineCancer So sad to see this. A legend and a wonderful human

[Tim Showalter @TimShowalter1]

@mschad15 @Sushilberiwal Can’t wait to see all of your future successes in rad onc!

[ArteraAI @arteraAI]

Did you catch Tim Showalter's presentation at #BiomarkersSeries23? 🇬🇧

Members of the Artera team met with attendees to discuss how the #ArteraAI #ProstateTest can help identify patients who will benefit from therapy intensification.

➡️ Learn more: https://t.co/KPIgvgOk9F